HomeATAI • NASDAQ
add
ATAI Life Sciences NV
Previous close
$1.58
Day range
$1.42 - $1.56
Year range
$1.03 - $2.85
Market cap
240.80M USD
Avg Volume
1.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 40.00K | -54.02% |
Operating expense | 22.64M | -15.89% |
Net income | -26.29M | -159.41% |
Net profit margin | -65.72K | -229.22% |
Earnings per share | -0.16 | -164.00% |
EBITDA | -22.52M | 15.85% |
Effective tax rate | 0.67% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 85.92M | -58.89% |
Total assets | 197.52M | -35.92% |
Total liabilities | 51.20M | 28.95% |
Total equity | 146.32M | — |
Shares outstanding | 167.80M | — |
Price to book | 1.82 | — |
Return on assets | -27.34% | — |
Return on capital | -31.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -26.29M | -159.41% |
Cash from operations | -19.34M | -4.94% |
Cash from investing | 24.84M | 153.44% |
Cash from financing | 4.89M | — |
Net change in cash | 10.63M | 116.46% |
Free cash flow | -8.37M | -669.63% |
About
Founded
2018
Website
Employees
83
